Skip to main content
(305) 420-5636
Studies Currently Enrolling

Join a Clinical Trial.
Help Shape the Future of Medicine.

Participate in cutting-edge research under the direct care of a board-certified physician, with all study-related care provided at no cost to you.

No-cost study-related care You may withdraw at any time IRB-approved & physician supervised

Open & Upcoming Studies

Filter by area to find a study that fits you. All trials are conducted under IRB oversight and follow FDA Good Clinical Practice guidelines.

Participants may be compensated for their time and travel. Compensation varies by study and is explained in full before you decide to take part.

Enrolling

Evaluating the efficacy and safety of the investigational medicine ALKS 2680 in adults with narcolepsy type 1. Two related ALKS 2680 protocols are enrolling at our site; our team will confirm which one fits you.

Duration
~3 months
Visits
8 clinic visits
Narcolepsy Type 2 — ALKS 2680
Phase 3 · Sleep Medicine
Enrolling

Evaluating the efficacy and safety of the investigational medicine ALKS 2680 in adults with narcolepsy type 2.

Duration
~3 months
Visits
7 clinic visits
Narcolepsy Type 1 & 2 — HBS-301
Phase 3 · Sleep Medicine
Enrolling

Efficacy and safety study of HBS-301 in participants with narcolepsy, followed by an open-label extension.

Duration
~4 months
Visits
5 clinic visits
Idiopathic Hypersomnia
Phase 3 · Sleep Medicine
Enrolling

Efficacy and safety study of HBS-301 in participants with idiopathic hypersomnia (IH), followed by an open-label extension.

Duration
~4 months
Visits
5 clinic visits
Narcolepsy Type 1
Phase 2a · Sleep Medicine
Enrolling

Evaluating the safety, tolerability, and efficacy of TAK-360 in participants with narcolepsy with cataplexy (type 1).

Duration
~4 months
Visits
~7 clinic visits
Narcolepsy Type 2 — TAK-360
Phase 2a · Sleep Medicine
Enrolling

Evaluating the safety, tolerability, and efficacy of TAK-360 in participants with narcolepsy without cataplexy (type 2).

Duration
~4 months
Visits
~7 clinic visits
Narcolepsy & Idiopathic Hypersomnia — ORX750
Phase 2a · Sleep Medicine
Enrolling

Study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ORX750 in adults with narcolepsy or idiopathic hypersomnia.

Duration
~3 months
Visits
5 clinic + 2 overnight visits
Narcolepsy Type 1 & 2 — Cleminorexton
Phase 2/3 · Sleep Medicine
Enrolling

A study investigating the effects of cleminorexton compared with placebo in participants with central disorders of hypersomnolence (narcolepsy type 1 or type 2).

Duration
~20 weeks
Visits
6 clinic + 4 overnight visits + 7 phone calls
Narcolepsy & Idiopathic Hypersomnia — Xywav
Phase 3 · Sleep Medicine
Enrolling Soon

Evaluating the efficacy and safety of Xywav expanded dosing regimens compared with placebo in adults with narcolepsy or idiopathic hypersomnia.

Duration
~4–6 weeks
Visits
8 clinic visits
Obstructive Sleep Apnea & Obesity — Eloralintide
Phase 3 · Obesity & Metabolism
Enrolling

Evaluating the efficacy and safety of eloralintide in participants with obstructive sleep apnea and obesity or overweight.

Duration
~18 months
Visits
15 clinic visits
Obstructive Sleep Apnea & Obesity — NNC0487-0111
Phase 3a · Obesity & Metabolism
Enrolling

Investigating how well the investigational medicine NNC0487-0111 helps people with excess body weight and obstructive sleep apnea not treated with positive airway pressure lose weight and improve their sleep apnea.

Duration
~22 months
Visits
16 clinic visits
Obesity
Phase 3a · Obesity & Metabolism
Enrolling

A research study investigating how well the investigational medicine zenagamtide helps people with excess body weight lose weight compared with semaglutide.

Duration
~22 months
Visits
18 clinic visits
Obstructive Sleep Apnea — Genio® Implant
Phase 4 · Sleep Medicine · Device study
Enrolling

Real-world study testing the safety and effectiveness of the Genio® System 2.1, a bilateral hypoglossal nerve stimulation implant, in adults with moderate-to-severe obstructive sleep apnea.

Duration
~5 years
Visits
9 visits (~2 per year)
Obstructive Sleep Apnea — Sensor Study
Observational · Sleep Medicine · Device study
Enrolling

A single-night study capturing thoracic movement during breathing with an accelerometer sensor while you undergo your already-scheduled overnight sleep study (PSG).

Duration
One night
Visits
2 visits
Shift Work Disorder
Phase 3 · Sleep Medicine
Enrolling

Assessing the efficacy and safety of solriamfetol for excessive sleepiness associated with shift work disorder.

Duration
~4 months
Visits
8 clinic visits
What to Expect

Your Journey, Step by Step

No surprises — here's exactly what happens after you apply.

1

Apply Online

Fill out the short form below — it takes about two minutes and is completely confidential.

2

Pre-Screening Call

A bilingual research coordinator calls you within 24 hours to ask brief eligibility questions.

3

Free Screening Visit

Visit our Miami office for a no-cost medical evaluation: history, physical exam, and any required tests.

4

Enroll & Begin

If eligible, you are officially enrolled and begin the study under direct physician supervision.

Your participation is always voluntary. You may leave a study at any time, for any reason — without affecting your regular medical care or your relationship with our physicians.

Get Started

See If You Qualify

Complete the form and a coordinator will reach out within 24 hours. Se habla español.

1
Your Info
2
Study Interest

Prefer to talk? Call (305) 420-5636 — Se habla español.

Participant FAQs

Questions? We Have Answers.

Everything you should know before joining a study.

What is a clinical trial?
A clinical trial is a carefully designed research study that evaluates whether an investigational medicine or device is safe and effective. Every trial at PharmaDev is reviewed and approved by an Institutional Review Board (IRB), follows FDA regulations and ICH Good Clinical Practice guidelines, and is conducted under the direct supervision of a board-certified physician.
Does it cost anything to participate?
No. All study-related medical care — exams, lab work, study medication, and monitoring — is provided at no cost to you. You do not need health insurance to participate.
Will I be compensated?
Participants may be compensated for their time and travel. Compensation varies by study and is explained in full before you decide to take part.
Is it safe? Can I leave a study at any time?
Your safety is our first priority. Every protocol is IRB-approved, you are monitored closely by our physicians at every visit, and our PI is available 24/7 for safety concerns. Participation is completely voluntary — you may withdraw at any time, for any reason, without affecting your regular medical care.
Will my information be kept private?
Yes. What you send us through this website is kept confidential and used only to see whether a study may suit you. If you go on to join a study, the consent form you sign explains exactly how your health information is used, who may see it, and the federal research regulations that protect it. Study data is coded, and your identity is never shared in published results.
¿Hablan español?
Sí. Nuestro equipo es bilingüe (inglés y español) y todos los documentos de consentimiento están disponibles en español. Llámenos al (305) 420-5636.

Still have questions? Call us at (305) 420-5636 — we're happy to talk it through, in English or Spanish.